ES2150797T3 - MULTIPLE COMPONENT SYSTEM FOR THE MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESSES FOR ITS USE. - Google Patents

MULTIPLE COMPONENT SYSTEM FOR THE MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESSES FOR ITS USE.

Info

Publication number
ES2150797T3
ES2150797T3 ES97952038T ES97952038T ES2150797T3 ES 2150797 T3 ES2150797 T3 ES 2150797T3 ES 97952038 T ES97952038 T ES 97952038T ES 97952038 T ES97952038 T ES 97952038T ES 2150797 T3 ES2150797 T3 ES 2150797T3
Authority
ES
Spain
Prior art keywords
lignin
materials
bleaching
degradation
modification
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES97952038T
Other languages
Spanish (es)
Inventor
Johannes Freudenreich
Jurgen Stohrer
Manfred Amann
Robert Muller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Consortium fuer Elektrochemische Industrie GmbH
Original Assignee
Consortium fuer Elektrochemische Industrie GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Consortium fuer Elektrochemische Industrie GmbH filed Critical Consortium fuer Elektrochemische Industrie GmbH
Application granted granted Critical
Publication of ES2150797T3 publication Critical patent/ES2150797T3/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C5/00—Other processes for obtaining cellulose, e.g. cooking cotton linters ; Processes characterised by the choice of cellulose-containing starting materials
    • D21C5/005—Treatment of cellulose-containing material with microorganisms or enzymes
    • D—TEXTILES; PAPER
    • D21—PAPER-MAKING; PRODUCTION OF CELLULOSE
    • D21C—PRODUCTION OF CELLULOSE BY REMOVING NON-CELLULOSE SUBSTANCES FROM CELLULOSE-CONTAINING MATERIALS; REGENERATION OF PULPING LIQUORS; APPARATUS THEREFOR
    • D21C9/00—After-treatment of cellulose pulp, e.g. of wood pulp, or cotton linters ; Treatment of dilute or dewatered pulp or process improvement taking place after obtaining the raw cellulosic material and not provided for elsewhere
    • D21C9/10—Bleaching ; Apparatus therefor
    • D21C9/1026—Other features in bleaching processes
    • D21C9/1036—Use of compounds accelerating or improving the efficiency of the processes

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Paper (AREA)
  • Detergent Compositions (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

A multicomponent system for modifying, decomposing or bleaching lignin, lignin-containing materials or similar substances contains (a) if required at least one oxidation catalyst, (b) at least one appropriate oxidising agent, and (c) at least one mediator characterised in that it is selected from the group composed of hydroxypyridine, aminopyridine, hydroxyquinoline, aminoquinoline, hydroxyisoquinoline, aminoisoquinoline, with nitroso or mercapto substituents at the ortho or para position with respect to the hydroxy or amino groups. Also disclosed are tautomers of said compounds, as well as their salts, ethers and esters.
ES97952038T 1996-12-09 1997-12-05 MULTIPLE COMPONENT SYSTEM FOR THE MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESSES FOR ITS USE. Expired - Lifetime ES2150797T3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19651099A DE19651099A1 (en) 1996-12-09 1996-12-09 Multi-component system for changing, breaking down or bleaching lignin, lignin-containing materials or similar substances as well as methods for their use

Publications (1)

Publication Number Publication Date
ES2150797T3 true ES2150797T3 (en) 2000-12-01

Family

ID=7814116

Family Applications (1)

Application Number Title Priority Date Filing Date
ES97952038T Expired - Lifetime ES2150797T3 (en) 1996-12-09 1997-12-05 MULTIPLE COMPONENT SYSTEM FOR THE MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESSES FOR ITS USE.

Country Status (12)

Country Link
EP (1) EP0943032B1 (en)
JP (1) JP2000505844A (en)
CN (1) CN1240008A (en)
AT (1) ATE196331T1 (en)
AU (1) AU719140B2 (en)
BR (1) BR9714387A (en)
CA (1) CA2271937A1 (en)
DE (2) DE19651099A1 (en)
ES (1) ES2150797T3 (en)
PT (1) PT943032E (en)
RU (1) RU2154704C1 (en)
WO (1) WO1998026127A1 (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6034047A (en) * 1998-09-04 2000-03-07 Au; Van Bleach detergent compositions comprising nitrones and nitroso spin traps
JP4092203B2 (en) 2000-12-21 2008-05-28 ニトロメッド，インク． Substituted aryl compounds, compositions, and methods of use as novel cyclooxygenase 2-selective inhibitors
DE60223904T2 (en) 2001-01-26 2008-11-27 Btg International Ltd. BENZYLAMINANALOGEN
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
EP1412367A4 (en) 2001-06-21 2006-05-03 Ariad Pharma Inc Novel quinolines and uses thereof
AU2003258630A1 (en) 2002-08-19 2004-03-11 Glaxo Group Limited Pyrimidine derivatives as selective cox-2 inhibitors
GB0221443D0 (en) 2002-09-16 2002-10-23 Glaxo Group Ltd Pyridine derivates
FI20031904A (en) * 2003-12-23 2005-06-24 Kemira Oyj Process for modifying a lignocellulosic product
CN101006076B (en) 2004-06-24 2010-09-29 沃泰克斯药物股份有限公司 Modulators of ATP-binding cassette transporters
US8354427B2 (en) 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
EP2332527A3 (en) 2004-10-20 2011-11-16 Resverlogix Corp. Flavanoids and Isoflavanoids for the prevention and treatment of cardiovascular diseases
AU2006275514B2 (en) 2005-07-29 2012-04-05 Resverlogix Corp. Pharmaceutical compositions for the prevention and treatment of complex diseases and their delivery by insertable medical devices
EP1919895A2 (en) 2005-08-02 2008-05-14 Lexicon Pharmaceuticals, Inc. 2-aminoaryl pyridines as protein kinases inhibitors
JP5409010B2 (en) 2005-12-28 2014-02-05 バーテックス ファーマシューティカルズ インコーポレイテッド Solid form of N- [2,4-bis (1,1-dimethylethyl) -5-hydroxyphenyl] -1,4-dihydro-4-oxoquinoline-3-carboxamide
BRPI0713153B8 (en) * 2006-06-13 2021-05-25 Helix Biomedix Inc tetrapeptide capable of inducing the production of extracellular matrix proteins and composition comprising
WO2008005910A2 (en) 2006-07-06 2008-01-10 Bristol-Myers Squibb Company Pyridone/hydroxypyridine 11-beta hydroxysteroid dehydrogenase type i inhibitors
PT2118074E (en) 2007-02-01 2014-03-20 Resverlogix Corp Compounds for the prevention and treatment of cardiovascular diseases
CA2711103C (en) 2008-06-26 2016-08-09 Resverlogix Corp. Methods of preparing quinazolinone derivatives
CA2747417C (en) 2009-01-08 2017-01-03 Resverlogix Corp. Compounds for the prevention and treatment of cardiovascular disease
CA3146333A1 (en) 2009-03-18 2010-09-23 Resverlogix Corp. Phenyl-quinazolin-4(3h)-one and phenyl-pyrido[2,3-d]pyrimidin-4(3h)-one derivatives and compositions thereof useful as anti-inflammatory agents
EP2821400B1 (en) 2009-03-20 2017-09-27 Vertex Pharmaceuticals Incorporated Process for making modulators of cystic fibrosis transmembrane conductance regulator
LT2421533T (en) 2009-04-22 2018-12-27 Resverlogix Corp. Novel anti-inflammatory agents
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
JP5992049B2 (en) 2011-11-01 2016-09-14 レスバーロジックス コーポレイション Oral immediate release formulations for substituted quinazolinones
MX2014010253A (en) 2012-02-27 2014-11-12 Vertex Pharma Pharmaceutical composition and administration thereof.
US9073878B2 (en) 2012-11-21 2015-07-07 Zenith Epigenetics Corp. Cyclic amines as bromodomain inhibitors
WO2014080291A2 (en) 2012-11-21 2014-05-30 Rvx Therapeutics Inc. Biaryl derivatives as bromodomain inhibitors
AU2013365926B9 (en) 2012-12-21 2019-01-17 Zenith Epigenetics Ltd. Novel heterocyclic compounds as bromodomain inhibitors
EP2970199A1 (en) 2013-03-11 2016-01-20 Bristol-Myers Squibb Company Isoquinolines as potassium ion channel inhibitors
WO2016057730A1 (en) 2014-10-07 2016-04-14 Strohmeier Mark Co-crystals of modulators of cystic fibrosis transmembrane conductance regulator
WO2016147053A1 (en) 2015-03-13 2016-09-22 Resverlogix Corp. Compositions and therapeutic methods for the treatment of complement-associated diseases
CN107245896A (en) * 2017-06-21 2017-10-13 昆明理工大学 A kind of method for improving pulp bleaching efficiency

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK77393D0 (en) * 1993-06-29 1993-06-29 Novo Nordisk As ENZYMER ACTIVATION
EP0717143A1 (en) * 1994-12-16 1996-06-19 Lignozym GmbH Multicomponents system for modifying decomposing or bleaching of lignin or materials containing it or similar components and the way to use it

Also Published As

Publication number Publication date
RU2154704C1 (en) 2000-08-20
ATE196331T1 (en) 2000-09-15
EP0943032B1 (en) 2000-09-13
CA2271937A1 (en) 1998-06-18
AU5560398A (en) 1998-07-03
JP2000505844A (en) 2000-05-16
AU719140B2 (en) 2000-05-04
DE59702358D1 (en) 2000-10-19
EP0943032A1 (en) 1999-09-22
WO1998026127A1 (en) 1998-06-18
DE19651099A1 (en) 1998-06-10
BR9714387A (en) 2000-05-16
CN1240008A (en) 1999-12-29
PT943032E (en) 2000-12-29

Similar Documents

Publication Publication Date Title
ES2150797T3 (en) MULTIPLE COMPONENT SYSTEM FOR THE MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESSES FOR ITS USE.
ES2138422T3 (en) SYSTEM OF VARIOUS COMPONENTS FOR MODIFICATION, DEGRADATION OR BLEACHING OF LIGNIN, MATERIALS CONTAINING LIGNIN OR ANALOGUE MATERIALS, AND PROCESS FOR ITS APPLICATION.
AR010385A1 (en) PROPIOPHENONE-DERIVED COMPOUND, PROCESS FOR ITS PREPARATION, PHARMACEUTICAL COMPOSITION CONTAINING IT AND USE OF SUCH COMPOUND.
ES2016585B3 (en) POLYBUTYLAMINS AND POLYISBUTYLAMINES, PROCEDURE FOR THE PREPARATION AND COMBUSTIBLE AND LUBRICANT COMPOSITIONS CONTAINING THESE SUBSTANCES.
DE3781061T2 (en) SUN PROTECTION AGENTS, SUN PROTECTION PREPARATIONS AND METHOD FOR PREVENTING THE SUN FIRE.
DK0739433T3 (en) Process for modifying, decomposing or bleaching lignin, lignin-containing materials or coal
BR9712680B1 (en) composition and method for treating plants with exogenous chemical substances.
DE3786879D1 (en) Bleaching agent compositions, persacuate-glycolate esters and precursors.
NO173976C (en) Improved metal-containing diagnostic agent
ES2120412T3 (en) ALKYLENE OXIDE CATALYSTS THAT HAVE IMPROVED ACTIVITY AND / OR STABILITY.
PT904110E (en) NITRIC OXIDE DONORS ABLE TO REDUCE TOXICITY CAUSED BY PHARMACIES
IT8621540A0 (en) SURFACTANTS DERIVED FROM BI- OR TRI-CARBOXYLIC HYDROXY ACIDS.
DE3280145D1 (en) ACRYLATE / MALEAT COPOLYMERISATE, THE PRODUCTION AND USE THEREOF AS A DEPOSITION PREVENTING AGENT.
MX9204031A (en) SALT OF L-ASCORBATE OF 16-DESCARBOXI-16-HIDROXIMETIL-AMFOTERICINA B, PROCESS FOR ITS PREPARATION AND PHARMACEUTICAL COMPOSITION CONTAINING SUCH SALT.
DE3585865D1 (en) AN ENZYME COMPOSITION AS A DIGESTIVE ACCELERATOR FOR DIFFERENT MIRRORS IN THE DIGESTIVE CHANNEL AND THEIR PRODUCTION PROCESS.
ES2104133T3 (en) COSMETIC OR PHARMACEUTICAL COMPOSITIONS CONTAINING GELEROPHOSPHOLIPIDS DESACLATED FOR TOPICAL USE.
DE69905392T2 (en) USE OF A PHARMACEUTICAL COMPOSITION CONTAINING AN ANTIQUE AGENT AND AT LEAST ONE PEPTIDE
PT97277A (en) METHOD FOR PREPARING PHARMACEUTICAL FORMULATIONS, CONTAINING, FOR EXAMPLE, CYCLOSPORIN A AND COLLATERAL POISON FACTOR, USEFUL FOR THE INHIBITION OF THE REACTION OF ALOENXERTO AND CONCORDING XENOENXERTO
BR9709564A (en) Process for producing lower sulfur aliphatic compounds and use of a morpholytic extractor
ITBO970266A0 (en) OPERATING MACHINE AND RELATED PROCESS, FOR THE PROCESSING OF PANELS.
DE50009238D1 (en) METHOD FOR REDUCING THE CONTENT OF POLYCHLORATED DIBENZOODIOXINES AND FURANS IN THE EXHAUST OF CHEMICAL HIGH TEMPERATURE PROCESSES
MX9205996A (en) NEW ANTIBIOTIC COMPOUND WITH ANTITUMORAL ACTIVITY, PHARMACEUTICAL COMPOSITION THAT CONTAINS IT AND PROCEDURE FOR ITS PREPARATION.
BR8104792A (en) (4,5B) QUINOXALINE DERIVATIVES 5.10, PERIDAZINE DIOXIDE PROCESS TO PREPARE THE SAME AND COMPOSITES CONTAINING THE SAME
Golden-Biddle et al. Nontraditional research: Editors' introduction
TH13669EX (en) 4, or 5 (subf) imio- and (sulphone) amidopiridine and piridine N-oxides of those substances, processes for their preparation and their use as medicine.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 943032

Country of ref document: ES